Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway

Fig. 4

Cordycepin increases osteosarcoma cell sensitivity to cisplatin by activating the AMPK signaling pathway and suppressing the AKT signaling pathway. a, b Western blotting analysis showing the protein expression levels of p-AMPK, p-AKT, p-mTOR, and p-p70S6K in U2OS and 143B osteosarcoma cells following a treatment with cordycepin (200 µM), cisplatin (1 µM), or their combination for 48 h

Back to article page